The toxicity of rifampicin polylactic acid nanoparticles againstMycobacterium bovis BCGand human macrophage THP-1 cell line
| Autor: | E. Rybalkina, G. E. Onishchenko, L. N. Lepekha, G Barsegyan, M. V. Erokhina |
|---|---|
| Rok vydání: | 2015 |
| Předmět: | |
| Zdroj: | IOP Conference Series: Materials Science and Engineering. 98:012017 |
| ISSN: | 1757-899X 1757-8981 |
| DOI: | 10.1088/1757-899x/98/1/012017 |
| Popis: | Tuberculosis is rapidly becoming a major health problem. The rise in tuberculosis incidence stimulates efforts to develop more effective delivery systems for the existing antituberculous drugs while decreasing the side effects. The nanotechnology may provide novel drug delivery tools allowing controlled drug release. Rifampicin is one of the main antituberculous drugs, characterized by high toxicity, and Poly (L-lactic acid) (PLLA) is a biodegradable polymer used for the preparation of encapsulated drugs. The aim of our work was to evaluate the toxicity of rifampicin-PLLA nanoparticles against Mycobacterium bovis BCG using human macrophage THP-1 cell line. Our data demonstrate that rifampicin-PLLA is effective against M. bovis BCG in the infected macrophages. The drug is inducing the dysfunction of mitochondria and apoptosis in the macrophages and is acting as a potential substrate of Pgp thereby modulating cell chemosensitivity. The severity of the toxic effects of the rifampicin-PLLA nanoparticles is increasing in a dose-dependent manner. We suggest that free rifampicin induces death of M. bovis BCG after PLLA degradation and diffusion from phago-lysosomes to cytoplasm causing mitochondria dysfunction and affecting the Pgp activity. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|